What Is The Long Shot?

Overview

The Long Shot groups three compounds that are each independently characterized in the literature on cellular metabolism, connective-tissue biology, and immune signalling. It ships as five separate vials, so the material corresponds to three distinct bodies of published work rather than to a single studied formulation.

NAD+ is a central redox coenzyme. Covarrubias et al. reviewed NAD+ metabolism and its roles in cellular processes during ageing, and Verdin surveyed its position in metabolism and neurodegeneration.[1][2] Rajman et al. reviewed the in vivo evidence for NAD-boosting molecules, and Imai and Guarente described the NAD+–sirtuin relationship.[3][4]

GHK-Cu is the copper-binding tripeptide first reported in Nature by Pickart et al. as a growth-modulating plasma tripeptide that may function by facilitating copper uptake into cells.[8] Maquart et al. reported stimulation of collagen synthesis in fibroblast cultures, and Pickart and Margolina reviewed its actions in light of gene-expression data.[9][11]

Thymosin Alpha-1 was isolated and sequenced by Goldstein et al. in 1977 as an immunologically active thymic polypeptide.[15] Romani et al. reported that it activates dendritic cells through toll-like receptor signalling, and Dominari et al. published a comprehensive review of the literature.[16][17]

No peer-reviewed study has evaluated these three compounds together as a kit. Every citation on this page describes a single component studied on its own, and the three act through unrelated molecular systems. Investigators should treat the kit as three separate research materials and consult the dedicated NAD+, GHK-Cu, and Thymosin Alpha-1 entries for complete mechanism, applications, and reference lists.